Three independent discounted-cash-flow-style models value Pfizer Inc. every trading day. 0 of 3 currently price PFE above its market price.
| Free Cash Flow model | $11.55 |
| Excess Profit model | $-3.85 |
| Residual Earnings model | $24.50 |
| Dividend Discount model | $42.07 |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +3.5% |
| Net debt / EBITDA | 11.1× |
| Gross margin | +74.3% |
| Revenue CAGR | -14.6% |
| Cash conversion | 1.5× |
| Dividend yield | +6.3% |
| Buyback yield | -0.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open PFE in StockKitty